Meet FinnGen at the ASHG 2026!
FinnGen booth
You can find us from the New Exhibitor Pavilion, booth number 1617!
Platform presentations
Wednesday Oct 21
Jonathan Davitte - Contextualizing and integrating All of Us with other global biobank data in drug discovery
Session: The All of Us Research Program At 10 Years: 500,000+ Genomes Advancing Precision, Room 517BC/Level 5 at 9:05 - 9:20 am
Théo Schneider - Accurate maternal and paternal haplotype inference reveals new parent-of-origin effects in the Finnish population
Session: Mapping Genetic Relatedness at Biobank Scale: Uncovering Hidden Signal from Rare Variants to Parent-of-Origin Effects, Room 710B/Level 7 at 11:15 am – 11:30 pm
Iris Heid - Longitudinal GWAS reveals the genetic architecture of kidney function across the life course in the population and disease
Session: The REnAL Deal: Genomic Insights into Kidney Disease, Room 516BC/Level 5 at 11:15 - 11:30 am
Masahiro Kanai - Population-scale immune multiome atlas of 10 million PBMCs reveals regulatory disease mechanisms in FinnGen
Session: Genetic Variation: From Catalogs to Consequences, Room 517A/Level 5 at 2:07-2:10 pm
Ivan Molotkov - Polygenic risk stratification identifies hypothyroid patients with skin cancer risk comparable to family history and UV-related risk
Session: Advancing Precision Oncology with AI, Functional Genomics, and Multi-Omics: From Risk Prediction to Tumor Evolution and Therapeutic Discovery, Room 510/Level 5 at 1:59 am – 2:02 pm
Posters
Wednesday Oct 21:
Juha Karjalainen - An auditable AI analyst for human genetics: 5.5 million fine-mapped credible sets, 935 real analyses, and a 112-protein hypothesis that survives its own negative control [Board No. 8113W]
Veikko Vuokila - A composite polygenic risk score of four prominent psychiatric disorders outperforms individual scores for shared comorbidity prediction in a large undiagnosed cohort [Board No. 8194W]
Linda Ottensmann - Clustering GWAS effect sizes across IBD surgical subtypes identifies variants influencing risk and [Board No. 8219W]
Isabel Kerrebijn - The genetic architecture of fibromyalgia across 2.5 million individuals [Board No. 8329W]
Dmitrii Usoltsev - Widespread heterogeneity in polygenic risk score effects across clinical histories in about 1 million individuals from UK Biobank and FinnGen [Board No. 8343W]
Thursday Oct 22:
Samuel Jones - Sex differences in the genetic architecture of common diseases are rare and often driven by phenotypic artefacts [Board No. 6070T]
Minna Karjalainen - Metabolic profiling of genetic variants associated with metabolic dysfunction-associated steatotic liver disease [Board No. 8282T]
A K Rafeul Hasan - Genetic architecture of 5-alpha reductase inhibitor users: a GWAS of the Finnish population [Presentation No. 8392T]
Noora Metsäranta - Genome-wide association study identifies 13 loci for ovarian mature teratoma and implicates meiotic cell cycle regulators [Presentation No. 8396T]
Michael Chao - Multi-omics evidence for type 2 diabetes in vascular dementia risk: implications for GLP-1 receptor agonists in neuroprotection [Board No. 8430T]
Ilona Uski - Recessive Mapping in FinnGen Identifies a Novel Locus nearby NLRP13 for Unexplained Female Infertility [Board No. 8439T]
Friday Oct 23:
Ivan Molotkov - Polygenic risk stratification identifies hypothyroid patients with skin cancer risk comparable to family history and UV-related risk factors [Board No. 1050F]
Masahiro Kanai - Population-scale immune multiome atlas of 10 million PBMCs reveals regulatory disease mechanisms in FinnGen [Board No. 6065F]
Sarah Snyder - BMI-restricted ascertainment inflates genetic associations between anorexia nervosa and body mass index [Board No. 8210F]
Jaakko Tyrmi - Genetic determinants of inpatient healthcare utilization [Board No. 8250F]
Zhiyu Yang - Large-Scale GWAS of Lab Value Trajectories Reveals Genetic Effects Distinct from Mean Levels [Board No. 8425F]
Hanna Ollila - Multiomic analysis of circadian and seasonal biomarkers [Board No. 8434F]